| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rhea S Ramnarine, Justin L Poklis, Carl E Wol. Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry. Journal of analytical toxicology. vol 43. issue 9. 2020-03-25. PMID:31436289. |
this has resulted in cannabinoids being more frequently identified in breast milk as a result of its high lipid content and cannabinoids having a high lipophilicity, thereby exposing the breastfeeding infant to cannabinoids and other marijuana constituents. |
2020-03-25 |
2023-08-13 |
Not clear |
| Josep Basas-Jaumandreu, F Xavier C de Las Hera. GC-MS Metabolite Profile and Identification of Unusual Homologous Cannabinoids in High Potency Cannabis sativa. Planta medica. vol 86. issue 5. 2020-03-25. PMID:32053835. |
gc-ms metabolite profile and identification of unusual homologous cannabinoids in high potency cannabis sativa. |
2020-03-25 |
2023-08-13 |
Not clear |
| Maykel Farag Ghabrash, Stephanie Coronado-Montoya, John Aoun, Andrée-Anne Gagné, Flavi Mansour, Clairélaine Ouellet-Plamondon, Annie Trépanier, Didier Jutras-Aswa. Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment. Psychiatry research. vol 286. 2020-03-24. PMID:32126328. |
cannabidiol is a cannabinoid with potential antipsychotic properties. |
2020-03-24 |
2023-08-13 |
human |
| Huiqiong Deng, Pratikkumar V Desai, Satyajit Mohite, Olaoluwa O Okusaga, Xiang Yang Zhang, David A Nielsen, Thomas R Koste. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. Journal of studies on alcohol and drugs. vol 80. issue 2. 2020-03-23. PMID:31014468. |
hospital stay in synthetic cannabinoid users with bipolar disorder, schizophrenia, or other psychotic disorders compared with cannabis users. |
2020-03-23 |
2023-08-13 |
Not clear |
| Theresa Mallick-Searle, Barbara St Mari. Cannabinoids in Pain Treatment: An Overview. Pain management nursing : official journal of the American Society of Pain Management Nurses. vol 20. issue 2. 2020-03-23. PMID:31036325. |
the current landscape contains conflicting reports regarding the use of medical marijuana, creating fields of misinformation and lack of understanding by health care providers about cannabinoids. |
2020-03-23 |
2023-08-13 |
Not clear |
| Eliza Jacobs-Brichford, Kirk F Manson, Jamie D Roitma. Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood. Physiology & behavior. vol 199. 2020-03-19. PMID:30529340. |
to model the effects of cannabis on mpfc function, we administered the synthetic cannabinoid win 55, 212-2 (win) to male and female rats from postnatal day 30-60. |
2020-03-19 |
2023-08-13 |
rat |
| Richard J Huntsman, Richard Tang-Wai, Alan E Shackelfor. Cannabis for Pediatric Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895184. |
the anticonvulsant properties of several cannabinoids, namely Δ-tetrahydrocannabinol and cannabidiol (cbd), have been demonstrated in both in vitro and in vivo studies. |
2020-03-18 |
2023-08-13 |
Not clear |
| Anna-Maria Smolyakova, Ayat Zagzoog, Asher L Brandt, Tallan Black, Kawthar Mohamed, Robert B Laprairi. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895186. |
cannabinoids are compounds that are structurally and/or functionally related to the primary psychoactive constituent of cannabis sativa, [increment]-tetrahydrocannabinol (thc). |
2020-03-18 |
2023-08-13 |
Not clear |
| Anna-Maria Smolyakova, Ayat Zagzoog, Asher L Brandt, Tallan Black, Kawthar Mohamed, Robert B Laprairi. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895186. |
this surge has been stimulated by an ongoing shift in societal opinions about cannabinoid-based medicines and evidence that cannabidiol, a nonintoxicating plant cannabinoid, has demonstrable anticonvulsant activity in children with treatment-refractory epilepsy. |
2020-03-18 |
2023-08-13 |
Not clear |
| Alexandra Carte. A North American History of Cannabis Use in the Treatment of Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895188. |
recently, academic interest has been renewed in cannabis, especially regarding the modulation of cortical excitability via the human endocannabinoid system. |
2020-03-18 |
2023-08-13 |
human |
| Alexandra Carte. A North American History of Cannabis Use in the Treatment of Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895188. |
legalization of marijuana in canada has potentially allowed for further trials, but it is by no means an end to the controversy surrounding the treatment of epilepsy with cannabinoids. |
2020-03-18 |
2023-08-13 |
human |
| Brian C Foster, Hanan Abramovici, Cory S Harri. Cannabis and Cannabinoids: Kinetics and Interactions. The American journal of medicine. vol 132. issue 11. 2020-03-16. PMID:31152723. |
cannabis and cannabinoids: kinetics and interactions. |
2020-03-16 |
2023-08-13 |
Not clear |
| Sang-Ho Choi, Yongshan Mou, Afonso C Silv. Cannabis and Cannabinoid Biology in Stroke. Stroke. vol 50. issue 9. 2020-03-12. PMID:31366312. |
cannabis and cannabinoid biology in stroke. |
2020-03-12 |
2023-08-13 |
Not clear |
| Gábor Xantus, Péter Kanizsa. [Vaping-associated lung injury]. Orvosi hetilap. vol 161. issue 11. 2020-03-12. PMID:32148093. |
in countries where cannabis has been legalised, vaporizers became an increasingly popular form of administration, however, no human studies have been performed with vaporized cannabinoid oils, hence the safety of such device is unknown. |
2020-03-12 |
2023-08-13 |
human |
| Allyson K Andrade, Briana Renda, Jennifer E Murra. Cannabinoids, interoception, and anxiety. Pharmacology, biochemistry, and behavior. vol 180. 2020-03-10. PMID:30922834. |
in this review, we discuss endocannabinoid activation and cannabis constituents from the perspective of subjective interoceptive (internally-perceived) states and how that relates to anxiety. |
2020-03-10 |
2023-08-13 |
human |
| Rabab Husain, Hannah Weeden, Daniel Bogush, Michihito Deguchi, Mario Soliman, Shobha Potlakayala, Ramesh Katam, Stephen Goldman, Sairam Rudrabhatl. Enhanced tolerance of industrial hemp (Cannabis sativa L.) plants on abandoned mine land soil leads to overexpression of cannabinoids. PloS one. vol 14. issue 8. 2020-03-09. PMID:31465423. |
enhanced tolerance of industrial hemp (cannabis sativa l.) plants on abandoned mine land soil leads to overexpression of cannabinoids. |
2020-03-09 |
2023-08-13 |
Not clear |
| Andrew Pen. Cannabinoids and Mental Health, Part 2: The Search for Clinical Applications. Journal of psychosocial nursing and mental health services. vol 57. issue 10. 2020-03-09. PMID:31573659. |
patients with psychiatric conditions are increasingly using cannabinoids, particularly cannabidiol (cbd), to treat their own symptoms. |
2020-03-09 |
2023-08-13 |
Not clear |
| Andrew Pen. Cannabinoids and Mental Health, Part 1: The Endocannabinoid System and Exogenous Cannabinoids. Journal of psychosocial nursing and mental health services. vol 57. issue 9. 2020-03-06. PMID:31461513. |
this foundational knowledge will help improve clinical interactions with patients who use cannabis and provide the necessary understanding of cannabinoids needed to undertake further scientific query into their purported benefits in psychiatric disease states. |
2020-03-06 |
2023-08-13 |
Not clear |
| Andrej Grigoryev, Pierce Kavanagh, Andrew Labutin, Alexandr Pechnikov, Geraldine Dowling, Vadim Shevyrin, Natalia Krupin. Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods. Drug testing and analysis. vol 11. issue 9. 2020-03-05. PMID:31243890. |
synthetic cannabinoids (scs), mimicking the psychoactive effects of cannabis, consist of a vast array of structurally diverse compounds. |
2020-03-05 |
2023-08-13 |
human |
| Thomas Duflot, Marianne Vasse, Jennifer Guillerme, Aurélien Schrapp, Celine Mory, Laurent Imbert, Zoubir Djerada, Yves Protais, Olivier Guillin, Hélène Goetz, Fabien Lamoureu. Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. Drug testing and analysis. vol 11. issue 9. 2020-03-05. PMID:31261442. |
interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. |
2020-03-05 |
2023-08-13 |
Not clear |